The Prevalence of Parent-Reported Autism Spectrum Disorder Among US Children
- PMID: 30478241
- PMCID: PMC6317762
- DOI: 10.1542/peds.2017-4161
The Prevalence of Parent-Reported Autism Spectrum Disorder Among US Children
Abstract
: media-1vid110.1542/5839990273001PEDS-VA_2017-4161Video Abstract OBJECTIVES: To estimate the national prevalence of parent-reported autism spectrum disorder (ASD) diagnosis among US children aged 3 to 17 years as well as their treatment and health care experiences using the 2016 National Survey of Children's Health (NSCH).
Methods: The 2016 NSCH is a nationally representative survey of 50 212 children focused on the health and well-being of children aged 0 to 17 years. The NSCH collected parent-reported information on whether children ever received an ASD diagnosis by a care provider, current ASD status, health care use, access and challenges, and methods of treatment. We calculated weighted prevalence estimates of ASD, compared health care experiences of children with ASD to other children, and examined factors associated with increased likelihood of medication and behavioral treatment.
Results: Parents of an estimated 1.5 million US children aged 3 to 17 years (2.50%) reported that their child had ever received an ASD diagnosis and currently had the condition. Children with parent-reported ASD diagnosis were more likely to have greater health care needs and difficulties accessing health care than children with other emotional or behavioral disorders (attention-deficit/hyperactivity disorder, anxiety, behavioral or conduct problems, depression, developmental delay, Down syndrome, intellectual disability, learning disability, Tourette syndrome) and children without these conditions. Of children with current ASD, 27% were taking medication for ASD-related symptoms, whereas 64% received behavioral treatments in the last 12 months, with variations by sociodemographic characteristics and co-occurring conditions.
Conclusions: The estimated prevalence of US children with a parent-reported ASD diagnosis is now 1 in 40, with rates of ASD-specific treatment usage varying by children's sociodemographic and co-occurring conditions.
Copyright © 2018 by the American Academy of Pediatrics.
Conflict of interest statement
POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.
Figures
Comment in
-
The Value of State Differences in Autism When Compared to a National Prevalence Estimate.Pediatrics. 2018 Dec;142(6):e20182950. doi: 10.1542/peds.2018-2950. Pediatrics. 2018. PMID: 30478239 Free PMC article. No abstract available.
References
-
- American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013
-
- Ritvo ER, Freeman BJ, Pingree C, et al. . The UCLA-University of Utah epidemiologic survey of autism: prevalence. Am J Psychiatry. 1989;146(2):194–199 - PubMed
-
- Newschaffer CJ, Falb MD, Gurney JG. National autism prevalence trends from United States special education data. Pediatrics. 2005;115(3). Available at: www.pediatrics.org/cgi/content/full/115/3/e277 - PubMed
-
- Centers for Disease Control and Prevention (CDC) Mental health in the United States: parental report of diagnosed autism in children aged 4-17 years–United States, 2003-2004. MMWR Morb Mortal Wkly Rep. 2006;55(17):481–486 - PubMed
